Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $139.3 billion, the company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Shares of this pharmaceutical giant have underperformed the broader market over the past year. PFE has declined 15.1% over this time frame, while the broader S&P 500 Ind ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third quarter, compared to the S&P 500’s 8.12 % return and the Russell 1000 Value’s 5.33% return. The firm is not happy with the flat performance of the portfolio, emphasizing its investments in real assets and brands that generate growing free cash flow (FCF) per share. Despite facing market pressures from speculati ...

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $12.1 billion, the company produces medicines for patients across a broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. The global healthcare giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Thursday, Nov. 6. Ahead of the event, analysts expect VTRS to report a profit of $0.63 per share on a dilut ...

AMSTERDAM, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Polpharma Group, one of the largest pharmaceutical groups operating across Central and Eastern Europe and Central Asia, announces a planned leadership transition. Effective January 1, 2026, Markus Sieger will step down as CEO of the Group , after a decade of dedicated service. He will continue to support the strategic development of the Group as a member of the Supervisory Board, in line with the succession plan agreed upon at the start of his tenure. Under Mark ...

Key Points Johnson & Johnson has one of the healthiest financial profiles in the world. PepsiCo backs its dividend with a rock-solid financial profile. Both companies have the financial fortitude to continue growing their dividends. 10 stocks we like better than Johnson & Johnson › Dividend Kings are in a league of their own. These companies have increased their dividends annually for at least the past 50 years. It's a short list, with only 56 companies currently making the cut. These extremely ...

公司投资动态 - 赛诺菲宣布向赛诺菲风险投资基金追加6.25亿美元投资 使该基金总资产超过14亿美元 [1] - 此次投资旨在支持该基金长期专注于生物技术和数字健康领域的初创公司 [2] - 赛诺菲风险投资基金自2012年成立以来 已向全球约70家公司投资超过8亿美元 投资阶段覆盖从早期种子轮到IPO [2] - 该基金通过参与被投公司董事会和协助退出等方式提供支持 [2] 公司业务概况 - 赛诺菲是一家总部位于法国的全球医疗保健公司 [3] - 公司业务包括药品、疫苗和消费者保健产品的研发、开发、生产和营销 [3]

Pfizer Inc. (NYSE:PFE) is one of the Best and Cheap Stocks to Buy Right Now. On September 30, Reuters reported that Pfizer Inc. (NYSE:PFE) and President Donald Trump had announced a deal to lower Medicaid drug prices in the US. The company agreed to match its Medicaid prices to those it charges in other developed countries in exchange for tariff relief on its imports. President Trump noted that Pfizer Inc. (NYSE:PFE) will offer its most favoured nation prices on all new drugs launched in the United States ...

电影行业关税政策 - 前总统特朗普宣布对进口外国电影征收100%关税，旨在解决美国电影业被“窃取”的问题 [2] - 美国股市整体反应平淡，但印度媒体公司PVR Inox和Prime Focus股价下跌5%，流媒体巨头Netflix股价在早盘交易中下跌1.5% [3] - 政策可行性受到质疑，加州州长加文·纽森批评该关税“100%愚蠢”，并警告可能对美国电影业造成“不可挽回的损害” [3] 家具与木材行业关税影响 - 宣布对进口木材征收10%关税，对厨房橱柜、浴室梳妆台和软垫家具征收25%关税，若相关国家未能达成协议，2026年税率将进一步提高 [4] - 关税依据1974年贸易法第232条实施，理由是对美国国家安全和国内木材产业构成威胁 [4] - 拥有大量国内制造业务的公司如橱柜制造商MasterBrand股价上涨近6%，而高端零售商RH和Williams-Sonoma股价承压 [5] - 加拿大木材生产商面临更大压力，新关税可能“加速加拿大供应的削减”，加拿大林产品协会谴责此举“鲁莽、损害经济并进一步破坏北美林业供应链” [5] 制药行业协议与市场反应 - 辉瑞公司同意在医疗补助计划中匹配海外最低药价，并承诺在美国制造业和研发领域投资700亿美元，同时推出直接面向消费者的折扣药销售平台“TrumpRx” [6] - 作为交换，辉瑞获得了计划中进口关税的三年豁免 [6] - 辉瑞股价在2025年9月30日大涨6.83%，收于25.48美元，成交量超过1.53亿股，接近其三个月平均水平的3.5倍 [7] - 标普500制药指数上涨近4%，其他主要制药公司如强生上涨2.09%，礼来公司上涨5.02% [8] - 分析师认为此为制药商的“广泛胜利”，可能为“其他制药公司设定路径”，但有专家对协议能否为美国人带来实质性节省表示怀疑 [8] 宏观经济与市场表现 - 尽管政府停摆的预测市场几率超过80%，但美国主要股指在2025年9月30日仍普遍上涨 [9] - 道琼斯工业平均指数微涨0.2%，收于46,397.89点的历史新高；标普500指数上涨0.4%至6,688.46点，连续第五个月上涨；纳斯达克综合指数上涨0.3%至22,660.01点，连续第六个月上涨 [9] - 分析师指出投资者似乎“忽略担忧”或已“消化停摆的潜在影响”，但新的关税正在“重新引发商业不确定性”， prolonged停摆可能延迟关键经济数据 [10] - 特朗普的贸易主管表示对华55%关税是“良好的现状”，欧洲央行行长认为欧洲经济在特朗普关税面前“表现优于预期” [11]

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Biopharmaceutical giant Amgen said it plans to invest $650 million to increase drug production at its Juncos, Puerto Rico, facility, as part of a larger effort to expand its U.S. manufacturing network. The investment is expected to create nearly 750 jobs, including in construction and highly-skilled manufacturing roles. It also will support advanced techn ...

公司公告与财务信息 - 赛诺菲2025年第三季度财务建模备忘录已发布，可在公司官网投资者页面获取 [1] - 该备忘录包含非可比项目、外汇影响和股本数量的提醒，旨在协助进行季度业绩财务建模 [1] - 公司2025年第二季度业绩将于2025年10月24日公布 [1] 公司概况与战略定位 - 赛诺菲是一家研发驱动、人工智能赋能的生物制药公司，致力于改善人类生活并实现强劲增长 [2] - 公司基于对免疫系统的深入理解，开发治疗和保护全球数百万人的药物和疫苗，其创新研发管线有望惠及更多人群 [2] - 公司在泛欧交易所和纳斯达克上市，交易代码分别为SAN和SNY [3] 投资者与媒体联系渠道 - 公司公布了媒体关系联系人名单，包括Sandrine Guendoul、Evan Berland等六位联系人的电话和邮箱 [4] - 公司公布了投资者关系联系人名单，包括Thomas Kudsk Larsen、Alizé Kaisserian等八位联系人的电话和邮箱 [4]